Sotera Health
S&P 400
$18.37
+0.60%
Delayed · cached 15 min
Fair value analysis
SHC
Sotera Health
$18.37
Close used for this calculation
$7.44Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
33/100
Quality radar
Consensus fair value
$7.44
Above FV▼ -59.5% against the close used
Model range $2.18 – $9.68
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear$2.18Fair value$7.44Bull$9.68
FairClose
52-week traded range
52W low $13.1352W high $19.57
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
Sotera Health closed at $18.37, 146.9% above the consensus fair value of $7.44 drawn from 7 valuation models.
Financial DNA score 33/100 — Weak. P/E of 68.0x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
$9.68
-47.3%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
P/E Fair Value
$5.40
-70.6%
EPS × 20x (sector P/E)
EPS=0.27, Sector P/E=20x
Peter Lynch (PEG)
$3.51
-80.9%
EPS × Growth% (PEG = 1 is fair)
EPS=0.27, g=13%
EV/EBITDA
$2.18
-88.2%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=242.41M
Book Value (P/B)
$2.88
-84.3%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=2.31, ROE=11.7%, g=3%, r=10%
Reverse DCF
$18.37
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 23.8% | Historical: -13%
Margin of Safety
$5.66
-69.2%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=7.54, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.